In Brief This Week: Sigma-Aldrich; Bruker, Vutara; Qiagen; Xifin; Enzo Biochem; Accelerator; Bio-Techne, ProteinSimple | GenomeWeb

NEW YORK (GenomeWeb) – Sigma-Aldrich said in its Form 10-Q filed last week with the US Securities and Exchange Commission that it expects to eliminate about 80 jobs resulting from an upcoming facility consolidation in Europe. Employee termination costs are anticipated to be around $4 million, while potential asset disposal costs are estimated at up to $12 million. The company said that it expects closure activities to begin in the second half of 2014. Sigma-Aldrich had about 9,000 employees as of Dec. 31, 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.